Europe Intra-Articular Injection for Osteoarticular Infiltrations Market 2031
The Europe intra-articular injection for osteoarticular infiltrations market size is projected to reach US$ 157.08 million by 2031 from US$ 97.43 million in 2023. The market is expected to register a CAGR of 6.2% during 2023–2031. The increasing number of clinical trials is expected to enhance the development of innovative products, which are likely to trend in the market during the forecast period.
Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Analysis
The rising incidence of osteoarthritis and other orthopedic disorders among the aging population and advancements made in injection techniques are factors contributing to market growth. In addition, the introduction of new formulations, increased awareness about joint health and the benefits of intra-articular injection, and higher healthcare spending in Europe that allows for better access to advanced treatment options, including intra-articular injections, are likely to fuel the Europe intra-articular injection for osteoarticular infiltrations market growth in the upcoming years.
Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Overview
Osteoarthritis is an inflammatory degenerative disease characterized by the deterioration of articular cartilage and underlying bone that predominantly affects the hip and knee. The increasing prevalence of osteoarthritis among the aging population, the growing need for effective treatments, and increased awareness among healthcare professionals and patients regarding the benefits of collagen injections have propelled the demand for intra-articular injections, thereby favoring the market growth. Recent advancements in hyaluronic acid injection therapy have significantly expanded growth trajectory, such as new formulations of hyaluronic acid—Durolane—sold by Nordic Medical Solutions ApS in Denmark, have improved patient outcomes and are widely adopted in clinics.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Europe Intra-Articular Injection for Osteoarticular Infiltrations Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Europe Intra-Articular Injection for Osteoarticular Infiltrations Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Drivers and Opportunities
Rising Prevalence of Osteoarthritis Favors Market Growth
Globally, osteoarthritis (OA) affects more than 500 million people, accounting for 7% of the world's population, including more than 10 million from France. According to the Centers for Disease Control and Prevention (CDC) report, OA represents a major cause of long-term disability. It is prevalent among athletes and people who sustain joint injury or trauma. It is also widely reported among women, accounting for 60% of the cases reported worldwide. According to the World Health Organization (WHO) report, the geriatric population is highly prone to the risk of OA. Although OA can affect anyone, the condition is most commonly observed in adults over 40 years of age. The Versus Arthritis 2024 report estimated that there were over 10 million people with OA in the UK, i.e., 5.4 million people suffering from knee OA and 3.2 million with hip OA. Additionally, according to the Osteoarthritis and Cartilage Open Journal published in 2024, there were ~5 million adults with knee OA patients in Germany, with an increasing prevalence of 7%. Thus, with the rising prevalence of OA, new therapy options such as intra-articular injections are gaining attention in Europe.
Strategic Initiatives by Market Players in Intra-Articular Injection for Osteoarticular Infiltrations
Intra-articular injection holds tremendous potential for the treatment of joint inflammation caused by injury or osteoarthritis. A few of the recent strategic initiatives by market players are mentioned below.
- In May 2024, VSY Biotechnology announced the global launch of Re-Cross by receiving “Play Sure Doping Free Certification” for its entire intra-articular HA portfolio. It is designed for pain management and the treatment of injury-related inflammatory and osteoarthritic conditions in sports medicine.
- In September 2023, KiOmed Pharma and Arsylab formed a strategic partnership for the promotion and distribution of Kiomedine one, a new class of treatment for refractory knee osteoarthritis in France. With such collaboration, KiOmed Pharma can offer a wide range of products for the treatment of osteoarthritis, thus enhancing its position in the market.
- Contura International Ltd launched a new hydrogel injection for knee osteoarthritis during the British Orthopaedic Association (BOA) Annual Congress, 21st–24th September 2021, in the UK to enable patients to regain mobility without surgery. The new hydrogel injection consists of non-biodegradable hydrogel technology—Arthrosamid.
Thus, continuous developments in intra-articular injection for osteoarticular infiltrations with increasing collaborations and partnerships are expected to present significant growth opportunities in the Europe intra-articular injection for osteoarticular infiltrations market in the coming years.
Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Report Segmentation Analysis
The key segments that contributed to the derivation of the Europe intra-articular injection for osteoarticular infiltrations market analysis are type and end user.
- Based on type, the Europe intra-articular injection for osteoarticular infiltrations market is bifurcated into Type 1 collagen and hyaluronic acid. The Type 1 collagen segment has been further segmented into polymerized, hydrolyzed, and atelocollagen types. The hyaluronic acid segment held a larger market share in 2023.
- By end user, the Europe intra-articular injection for osteoarticular infiltrations market is divided into hospitals, orthopedic clinics, and others. The hospitals segment dominated the market in 2023. The orthopedic clinics segment is anticipated to register the highest CAGR during 2023–2031.
Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Share Analysis by Country
The scope of the Europe intra-articular injection for osteoarticular infiltrations market report is mainly divided into Germany, the UK, France, Italy, Spain, Denmark, and the Rest of Europe. Germany held a significant share of the market in 2023. The growth of the market is driven by the growing elderly population, rising research and development activities, and advancements in intra-articular injections. Aging population has been a major contributor to the elevated demand for intra-articular injections for treating osteoarticular disorders in the country. Osteoarthritis in the lower extremities (hips and knees) causes more mobility loss than in the upper extremities. These conditions can be managed and treated with the use of knee hyaluronic acid injection treatment; thus, it has great potential for growth and provides a rewarding opportunity to the players serving in this market. In addition, the presence of various players offering intra-articular injection treatment and conducting clinical trials favors the market growth in Germany.
Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Report Scope
Europe Intra-Articular Injection for Osteoarticular Infiltrations Market News and Recent Developments
The Europe intra-articular injection for osteoarticular infiltrations market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the Europe intra-articular injection for osteoarticular infiltrations market are listed below:
- Maxigen Biotech Inc. (MBI) signed an exclusive distribution agreement with Mars Medicine Sağlık Ürünleri Limited Şirketi, one of the largest distributors of pharmaceutical products in Turkey, as Maxigen Biotech’s long-term, strategic partner in opening the Turkish market. This partnership aims to provide the best intra-articular injection technology to medical institutions in Turkey by supplying MBI’s products, which offer patients a full range of knee treatment solutions. Due to Turkey’s crucial location between the Middle East and Europe, this alliance will accelerate MBI’s expansion in those markets. (Source: Maxigen Biotech Inc., Press Release, November 2022)
- Contura Orthopaedics Ltd collaborated with Horizon Lab Company, one of Italy’s leading independent medical device distributors, to promote patient access to its unique treatment—Arthrosamid—in Europe. (Source: Contura Orthopaedics Ltd, Press Release, June 2022)
Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Report Coverage and Deliverables
The “Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Europe intra-articular injection for osteoarticular infiltrations market size and forecast at regional and country levels for all the key market segments covered under the scope
- Europe intra-articular injection for osteoarticular infiltrations market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Europe intra-articular injection for osteoarticular infiltrations market analysis covering key market trends, regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Europe intra-articular injection for osteoarticular infiltrations market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The rising prevalence of osteoarthritis and advancements in injection techniques are the most influential factors responsible for the market growth.
The Europe intra-articular injection for osteoarticular infiltrations market is estimated to register a CAGR of 6.2% from 2023 to 2031.
The value of the Europe intra-articular injection for osteoarticular infiltrations market is estimated to reach US$ 157.08 million by 2031.
Bioventus Inc., SEIKAGAKU CORPORATION, Maxigen Biotech Inc., İstem Medical Inc., Sanofi SA, Ferring Pharmaceuticals, Fidia Pharma USA Inc., Biotech Healthcare Group, Bioteck S.p.A., and I+MED are among the key market players in the Europe intra-articular injection for osteoarticular infiltrations market.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Information on why collagen injections are better than HA injections
4.4 Pricing Analysis
5. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Key Market Dynamics
5.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Osteoarthritis
5.2.2 Advancements in Injection Techniques
5.3 Market Restraints
5.3.1 Side Effects Associated with Intra-Articular Injections
5.4 Market Opportunities
5.4.1 Strategic Initiatives in Intra-Articular Injection for Osteoarticular Infiltrations
5.5 Future Trends
5.5.1 Increasing Number of Clinical Trials
5.6 Impact of Drivers and Restraints:
6. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis
6.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue (US$ Million), 2021–2031
6.2 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Forecast and Analysis
7. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis – by Type
7.1 Type 1 Collagen
7.1.1 Overview
7.1.2 Type 1 Collagen: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Hyaluronic Acid
7.2.1 Overview
7.2.2 Hyaluronic Acid: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis – by End User
8.1 Hospitals
8.1.1 Overview
8.1.2 Hospitals: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Orthopedic Clinics
8.2.1 Overview
8.2.2 Orthopedic Clinics: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Country Analysis
9.1 Europe
9.1.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Countries
9.1.2 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue and Forecast and Analysis – by Country
9.1.2.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue and Forecast and Analysis – by Country
9.1.2.2 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.2.1 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
9.1.2.2.2 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
9.1.2.2.3 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
9.1.2.3 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.3.1 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
9.1.2.3.2 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
9.1.2.3.3 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
9.1.2.4 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.4.1 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
9.1.2.4.2 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
9.1.2.4.3 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
9.1.2.5 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.5.1 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
9.1.2.5.2 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
9.1.2.5.3 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
9.1.2.6 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.6.1 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
9.1.2.6.2 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
9.1.2.6.3 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
9.1.2.7 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.7.1 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
9.1.2.7.2 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
9.1.2.7.3 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
9.1.2.8 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.8.1 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
9.1.2.8.2 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
9.1.2.8.3 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
10. Industry Landscape
10.1 Overview
10.2 Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Bioventus Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 SEIKAGAKU CORPORATION
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Maxigen Biotech Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 ?stem Medical Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Sanofi SA
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Ferring Pharmaceuticals
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Fidia Pharma USA Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Biotech Healthcare Group
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Bioteck S.p.A.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 I+MED
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
List of Tables
Table 1. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Segmentation
Table 2. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 4. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 5. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 6. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Country
Table 7. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 8. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 9. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 10. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 11. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 12. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 13. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 14. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 15. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 16. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 17. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 18. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 19. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 20. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 21. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 22. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 23. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 24. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 25. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 26. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 27. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 28. Recent Organic Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market
Table 29. Recent Inorganic Growth Strategies in the Intra-Articular Injection For Osteoarticular Infiltrations Market
Table 30. Glossary of Terms, Europe Intra-Articular Injection For Osteoarticular Infiltrations Market
List of Figures
Figure 1. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue (US$ Million), 2021–2031
Figure 5. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Share (%) – by Type, 2023 and 2031
Figure 6. Type 1 Collagen: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Hyaluronic Acid: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Share (%) – by End User, 2023 and 2031
Figure 9. Hospitals: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Orthopedic Clinics: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Others: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 13. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market
The List of Companies - Europe Intra-Articular Injection For Osteoarticular Infiltrations Market
- Bioventus Inc.
- SEIKAGAKU CORPORATION
- Maxigen Biotech Inc.
- Istem Medical Inc.
- Sanofi SA
- Ferring Pharmaceuticals
- Fidia Pharma USA Inc.
- Biotech Healthcare Group
- Bioteck S.p.A.
- I+MED.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For